There is so much interest in Cynata's lead Cymerus™ mesenchymal stem cell (MSC) product, and we
are in bed with 2 multi billion companies, and the clinical trial with MHRA, which is only a formality,
and if the trial had any chance of being negative, Fuji would have waited for confirmation.
And this has created HUGE interest in the stem cell industry.
I can see $2 by dec - jan
Cynata. How high, how soon?, page-16
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.5¢ | $480 | 2.343K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15128 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 43657 | 1 |
View Market Depth
| Last trade - 15.39pm 02/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |